<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0400966" disease_type="Disease or Syndrome" abbrv="">Nonalcoholic steatohepatitis</z:e> (NASH) represents an advanced stage of <z:hpo ids='HP_0001397'>fatty liver</z:hpo> disease developed in the absence of <z:e sem="disease" ids="C0085762" disease_type="Mental or Behavioral Dysfunction" abbrv="aca">alcohol abuse</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Its increasing prevalence in western countries, the diagnostic difficulties by noninvasive tests, and the possibility of progression to advanced <z:mp ids='MP_0003045'>fibrosis</z:mp> and even <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> make NASH a challenge for hepatologists </plain></SENT>
<SENT sid="2" pm="."><plain>NASH is frequently associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, and several genetic and acquired factors are involved in its pathogenesis </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> plays a central role in the development of a steatotic liver, which becomes vulnerable to additional injuries </plain></SENT>
<SENT sid="4" pm="."><plain>Several cyclic mechanisms leading to self-enhancement of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and hepatic accumulation of fat have been recently identified </plain></SENT>
<SENT sid="5" pm="."><plain>Excess intracellular fatty acids, oxidant stress, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha, and <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction are causes of hepatocellular injury, thereby leading to disease progression and to the establishment of NASH </plain></SENT>
<SENT sid="6" pm="."><plain>Intestinal <z:mp ids='MP_0001794'>bacterial</z:mp> <z:hpo ids='HP_0001548'>overgrowth</z:hpo> also plays a role, by increasing production of endogenous <z:chebi fb="37" ids="16236,44730">ethanol</z:chebi> and proinflammatory cytokines </plain></SENT>
<SENT sid="7" pm="."><plain>Therapeutic strategies aimed at modulating <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, normalizing <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> metabolism, and downregulating <z:mp ids='MP_0002501'>inflammatory mediators</z:mp> with probiotics have promising potential </plain></SENT>
</text></document>